Cargando…
Reprogramming Metabolism of Macrophages as a Target for Kidney Dysfunction Treatment in Autoimmune Diseases
Chronic kidney disease (CKD), as one of the main complications of many autoimmune diseases, is difficult to cure, which places a huge burden on patients’ health and the economy and poses a great threat to human health. At present, the mainstream view is that autoimmune diseases are a series of disea...
Autores principales: | Tian, Feng, Chen, Hui, Zhang, Jianmin, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316004/ https://www.ncbi.nlm.nih.gov/pubmed/35887371 http://dx.doi.org/10.3390/ijms23148024 |
Ejemplares similares
-
Glucose metabolic reprogramming in autoimmune diseases
por: Jeong, Hoim, et al.
Publicado: (2023) -
Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
por: Wang, Mengdi, et al.
Publicado: (2022) -
Metabolic reprogramming in macrophage responses
por: Liu, Yang, et al.
Publicado: (2021) -
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
por: Li, Yin, et al.
Publicado: (2021) -
Metabolic Reprograming in Macrophage Polarization
por: Galván-Peña, Silvia, et al.
Publicado: (2014)